Read the latest project news in the COLOSSUS Winter 2019 newsletter. Get an update on the COLOSSUS translational trial and read the dissemination highlights too. In this edition, their ‘Partner in the Spotlight” is Cancer Trials Ireland. Download the newsletter here.
COLOSSUS aims to provide new and more effective ways to classify people with microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC for short and to develop new treatments for them. The ultimate goal is to deliver a new, personalised medicine approach for people with MSS RAS mt mCRC.
COLOSSUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 754923.